Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

Inozyme Pharma Stock

Q: How to sell Inozyme Pharma stock?

If you hold private company shares of Inozyme Pharma - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your Inozyme Pharma stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

inozyme.comHealthcare / BioTech & PharmaFounded: 2016Funding to Date: $115.85MM

Inozyme Pharma is a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases.

Buy or sell Inozyme Pharma stockLearn more about Inozyme Pharma IPO

OverviewFinancingsValuation

Enterprise Value

Access Inozyme Pharma’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Inozyme Pharma.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Henric Bjarke

Chief Operating Officer & Senior Vice President

Stephen Basso

Vice President of Finance

Joseph Schlessinger Ph.D

Co-Founder & Chairman

Steven Jungles

Chief Technical Operations Officer & Senior Vice President

David Thompson

Senior Vice President & Chief Scientific Officer

Eric Yuen MD

Chief Medical Officer & Senior Vice President

Axel Bolte

Co-Founder, Chief Executive Officer, President & Board Member

Ruhi Ahmed Ph.D

Vice President of Regulatory and Government Affairs

Demetrios Braddock Ph.D

Scientific Founder, Chairperson of Scientific Advisory Board and Board Observer

Board Members

Axel Bolte

Joseph Schlessinger Ph.D

Rob Hopfner

Demetrios Braddock Ph.D

Martin Edwards MD

Novo Holdings

Ruchita Sinha

Sanofi-Genzyme Bioventures

Edward Mathers

New Enterprise Associates

Reinaldo Diaz

Longitude Capital

Sarah Bhagat Ph.D

Sofinnova Investments

Inozyme Pharma stock FAQs

Can you buy Inozyme Pharma stock?

As Inozyme Pharma is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Inozyme Pharma, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Inozyme Pharma stock?

To invest in a private company like Inozyme Pharma through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Inozyme Pharma stock?

Yes, you may be able to sell your Inozyme Pharma stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Inozyme Pharma stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Inozyme Pharma stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Inozyme Pharma a public company?

No, Inozyme Pharma is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Inozyme Pharma’s stock price?

Inozyme Pharma is a privately held company and therefore does not have a public stock price. However, you may access Inozyme Pharma’s private market stock price with Forge Data.

What is Inozyme Pharma’s stock ticker symbol?

Inozyme Pharma does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Business Wire 11/14/2019

Inozyme Pharma Expands Medical Leadership Team

Inozyme Pharma today announced the addition of three industry veterans to its leadership team.

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.